Editorial Volume 12 Issue 1
1The Father of Andrology” Director & Chief of Andrology, Andrology Institute of America, Lexington, Kentucky, USA
2Visiting Scholar Andrology Institute of America
Correspondence: Panayiotis Zavos, The Father of Andrology” Director & Chief of Andrology, Andrology Institute of America, Lexington, Kentucky, USA
Received: January 25, 2023 | Published: March 23, 2023
Citation: Zavos P, Zavos TM. The future of the stem cells: what they are, what they do and what they could be doing? MOJ Women’s Health. 2023;12(1):1-3. DOI: 10.15406/mojwh.2023.12.00309
The potential of stem cell research is almost biblical in its scale and is expanding its potential by limbs and bounds daily. The capacity for these cells to transform into whatever cells or tissues the body may need to regenerate itself could, in the lifetime of the next generation, make the blind see, the spinal cord injured walk, the diabetics healthy and the infertile able to procreate. It could cure cystic fibrosis and arrest muscular dystrophy. Yet it also raises one of the most difficult dilemmas in medical research: ensuring that something which could offer huge rewards to the world's health is not overlooked because it does not offer huge rewards to the national economy and its political leadership. But in spite of those shortcomings, the future lies ahead with those potent cells the body is fortunate to have access to. I recall when I appeared before the Congress of the United States in March of 2001, I reminded this dysfunctional political entity that a cell has been discovered, namely the stem cell which when used and harnessed properly it can change the way we may approach therapeutic medicine as we know it for the future. Scientist first managed to culture embryonic stem cells in 1998 and the fight for stem cells began at that time. However, the fight led us into a somewhat confused direction which also prompted President Bush to ban all research on human embryological stem cell which also managed to put the United States way back in the race for all the advancements that should be forthcoming. It took the US several years to recover from all the advancements in this exciting field and today the USA is still lacking behind other leading countries in the World because of bad decisions made by naïve and ill driven politicians and other entities at the early stages of this very important scientific breakthrough. It is vital that in the light of the dazzling potential of human embryonic stem cell research, and the money that could one day be made from it, we also keep a watchful eye for treatments only public finance will back. That is what happens when true leadership by unambitious and unmotivated politicians is nowhere to be found.
Stem cells are the body's basic cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle or bone. No other cell in the body has the natural ability to generate new cell types as the stem cells do.
Where do stem cells come from?
Scientists have discovered several sources of stem cells in various compartments of the body:
Controversies: why is there a controversy about using embryonic stem cells?
As well established, embryonic stem cells are obtained from early-stage embryos (morulae or blastocysts) which is a group of cells that forms when a woman's egg is fertilized with a man's sperm naturally or during IVF. Because the procedure necessitates that human embryonic stem cells are extracted from human embryos, several questions and issues have been raised about the ethics and morality of any studies performed using such cells obtained via an invasive procedure performed on embryos.
The National Institutes of Health created guidelines for human stem cell research in 2009. Those guidelines are quite restrictive and seek the definition of embryonic stem cells and how they may be used in research and donation guidelines for embryonic stem cells. In addition, guidelines tend to restrict that embryonic stem cells may only be used from embryos created by in vitro fertilization when only when the embryo is no longer needed, and which may be donated voluntarily and with the consent of the intended parents.
Why can't researchers use adult stem cells instead?
Although research into adult stem cells is promising, adult stem cells may not be as versatile and durable as are embryonic stem cells. Adult stem cells may not be able to be manipulated to produce all cell types, which limits how adult stem cells can be used to treat diseases. Adult stem cells also are more likely to contain abnormalities due to environmental hazards, such as toxins, or from errors acquired by the cells during replication. However, researchers have found that adult stem cells are more adaptable than was initially suspected. Stem cells and derived products offer great promise for new medical treatments. More needs to be learned about stem cell types, current and possible uses, ethical issues, and the state of research and practice, today and the future.
It has been very well documented, and one may have heard about stem cells in various publications and perhaps one may have wondered if they might help people with needs and with a serious disease. One may wonder what stem cells are, how they're being used to treat disease and injury, and why they're the subject of such vigorous debate. Here are some answers to frequently asked questions about stem cells.
Why is there such an interest in stem cells?
Researchers and doctors hope stem cell studies can help to:
New areas of study include the effectiveness of using human stem cells that have been programmed into tissue-specific cells to test new drugs. For testing of new drugs to be accurate, the cells must be programmed to acquire properties of the type of cells to be tested. Techniques to program cells into specific cells continue to be studied. For instance, nerve cells could be generated to test a new drug for a nerve disease. Tests could show whether the new drug had any effect on the cells and whether the cells were harmed.
The future: where do we go from here?
In a field that has such incredible potential, delays are hard to live with and mis directions of such efforts can be devastating. Every year of waiting means that babies with fatal congenital defects can’t be treated, diabetics continue to die early, damaged hearts can’t be healed. Scientists who have been working for decades to harness the curative powers of stem cells have not forgotten these grand goals. Many are now within touching distance of delivering transformative therapies. Cell therapy trials for age-related macular degeneration and other forms of blindness are delivering promising results; Most recently, scientists came significantly closer to building a pipeline to manufacture vast quantities of Lab-grown blood: a study in monkeys suggested that implanting neurons derived from stem cells could help treat Parkinson’s and those exciting break throughs are too numerous to mention. In short, the sky is the limit and let’s not jeopardize the future for those that care about it.
None.
The author declares there is no conflict of interest.
©2023 Zavos, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.